TBE Seropersistence up to 10 Years After First Booster in Adults
NCT01582698
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
243
Enrollment
INDUSTRY
Sponsor class
Conditions
Tick-borne Encephalitis (TBE)
Interventions
BIOLOGICAL:
FSME-IMMUN 0.5 ml
Sponsor
Pfizer